#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11446	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2192	517.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1538	1538	C	680	C	657	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11446	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2192	517.0	0	HET	.	.	.	C207T	.	207	207	C	561	561	C	616	C,T	488,99	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11446	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2192	517.0	0	HET	.	.	.	C451T	.	451	451	C	805	805	C	659	C,T	452,186	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20744	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3474	593.1	0	.	n	.	0	T695C	SNP	695	695	T	1028	1028	C	629	C	610	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20744	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3474	593.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2304	2304	C	593	C,T	566,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20744	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3474	593.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2378	2378	A	595	A	578	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20744	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3474	593.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2930	2930	C	638	C,T	616,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1212	folP	855	855	100.0	folP.l15.c30.ctg.1	1649	72.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1058	1060	AGC	122;121;121	A;G;C	115;117;113	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3876	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3249	118.4	1	SNP	p	S91F	1	.	.	271	273	TTC	513	515	TTC	134;133;131	T;T;C	130;125;126	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3876	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3249	118.4	1	SNP	p	D95G	1	.	.	283	285	GGC	525	527	GGC	136;134;136	G;G,C;C	128;124,1;126	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3876	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3249	118.4	1	SNP	p	G95N	0	.	.	283	285	GGC	525	527	GGC	136;134;136	G;G,C;C	128;124,1;126	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1124	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1437	77.8	1	SNP	p	G45D	0	.	.	133	135	GGC	599	601	GGC	151;154;155	G;G;C	145;148;148	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	596	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1054	56.5	0	.	n	.	0	A197.	DEL	197	197	A	643	643	A	134	A	130	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3636	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	125.1	1	SNP	p	D86N	0	.	.	256	258	GAC	557	559	GAC	117;118;119	G;A;C	115;113;116	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3636	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	125.1	1	SNP	p	R87I	0	.	.	259	261	CGT	560	562	CGT	119;119;120	C;G;T	117;116;117	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3636	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	125.1	1	SNP	p	R87W	0	.	.	259	261	CGT	560	562	CGT	119;119;120	C;G;T	117;116;117	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3636	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	125.1	1	SNP	p	S87R	1	.	.	259	261	CGT	560	562	CGT	119;119;120	C;G;T	117;116;117	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3636	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	125.1	1	SNP	p	S88P	0	.	.	262	264	TCC	563	565	TCC	121;122;122	T;C;C	117;116;116	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2674	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2599	102.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1546	1548	GGC	119;117;113	G;G;C	112;111;107	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1147	1149	GCC	182;183;183	G;C,T;C	169;171,1;170	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1150	1152	ATG	186;188;187	A;T;G	173;173;174	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1162	1164	ACC	182;184;183	A;C;C	169;175;174	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1162	1164	ACC	182;184;183	A;C;C	169;175;174	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1663	1665	ACC	145;146;147	A,G;C;C	135,1;141;142	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1717	1719	GCG	135;133;131	G;C;G	131;130;129	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1717	1719	GCG	135;133;131	G;C;G	131;130;129	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1840	1842	GGT	113;112;109	G;G;T,C	109;109;101,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1849	1851	AGC	99;99;100	A,G;G;C	93,1;94;96	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2904	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2310	124.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1867	1869	CCG	82;84;84	C,G,T;C,G;G,C	64,5,1;68,1;68,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4470	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3089	144.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1645	1647	CCG	150;151;153	C,G;C;G	137,1;142;141	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1838	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1759	103.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	580	580	C	113	C	106	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2496	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1661	149.4	0	.	p	.	0	E209K	NONSYN	625	627	GAA	965	967	AAA	224;225;227	A;A;A	219;219;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2496	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1661	149.4	0	.	p	.	0	A212E	NONSYN	634	636	GCA	974	976	GAA	221;219;219	G;A,G;A	216;214,1;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2496	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1661	149.4	1	SNP	p	G120K	1	.	.	358	360	AAG	698	700	AAG	198;197;195	A;A;G	188;190;180	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2496	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1661	149.4	1	SNP	p	A121N	1	.	.	361	363	AAC	701	703	AAC	196;199;200	A,G;A;C,A	181,1;192;189,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2496	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1661	149.4	1	SNP	p	N121D	0	.	.	361	363	AAC	701	703	AAC	196;199;200	A,G;A;C,A	181,1;192;189,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8486	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4752	177.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	946	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1046	89.4	1	SNP	p	V57M	1	.	.	169	171	ATG	478	480	ATG	210;210;215	A;T;G	204;206;209	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
